Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Institutional Review Board & Ethics Committee

Latest News

July 1st 2026
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
By Elizabeth Walsh, PMP, ACRP-CP

Protocol assumptions about patients, visit schedules, timelines, and vendors are rarely tested against operational reality until startup, but early engagement of experienced execution strategists can identify and mitigate feasibility gaps before commitments harden into expensive course corrections.

© Egor - © Egor - stock.adobe.com
October 31st 2025

Engineered Bispecific Antibodies: Regulatory, Ethical, and Best Practice Guidelines

By Sharad Adekar, MD, PhD, CIP, Currien MacDonald
July 8th 2025

Obsolete Trial Marketing Guidelines and Missing Processes Hurt Patient Enrollment

By Christine Senn, PhD, FACRP
© putilov_denis - © putilov_denis - stock.adobe.com
May 12th 2025

3 Common eCOA Implementation Challenges and How to Solve Them

By Chase Carmeans
© photon_photo - © photon_photo - stock.adobe.com.
April 28th 2025

The Latest Advancements in Single Sign-On Technology

By Stuart Cotter
Advertisement

Latest Videos

Empowering Clinicians to Communicate Clinical Trial Opportunities Effectively
Empowering Clinicians to Communicate Clinical Trial Opportunities Effectively

Advertisement

More News

Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

2

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

3

Bringing the Voice of Clinical Practice and Patients into Drug Development

4

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

5

ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us